Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Caring Brands, Inc.CABR · Entity 7825 | Chief Financial Officer | September 28, 2026 | September 30, 2026 |
| JONES SODA CO.JSDA · Entity 7351 | Chief Financial Officer | August 06, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Caring Brands, Inc.
Report date September 28, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.24 · Expires 2031-09-28 | Direct | 25,000 |
Reported balance
After 2026-09-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-28 · Grant · Acquired 25,000 · Balance 25,000 F1: On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan. F2: The options vested immediately on September 28, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.
F2: The options vested immediately on September 28, 2026.
JONES SODA CO.
Report date August 06, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 303,030 |
Reported balance
After 2026-08-06 transaction · row 1
1 source rowRow 1 · 2026-08-06 · Purchase · Acquired 303,030 · Balance 303,030 F1: The reported securities are included within 303,030 Investor Units (the "Units") purchased by the reporting person from the issuer for a price of $0.33 per Unit in a private placement transaction (the "Private Placement"). Each Unit is comprised of one (1) share of the issuer's common stock (a "Share") plus one half (1/2) of a Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to purchase one (1) Share (a "Warrant Share") at an exercise price of $0.45 per Warrant Share. |
| Common Stock Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.45 · Expires 2029-08-06 | Direct | 151,515 |
Reported balance
After 2026-08-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-06 · Purchase · Acquired 151,515 · Balance 151,515 F1: The reported securities are included within 303,030 Investor Units (the "Units") purchased by the reporting person from the issuer for a price of $0.33 per Unit in a private placement transaction (the "Private Placement"). Each Unit is comprised of one (1) share of the issuer's common stock (a "Share") plus one half (1/2) of a Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to purchase one (1) Share (a "Warrant Share") at an exercise price of $0.45 per Warrant Share. F2: The Warrants may be exercised for 36 months following the completion of the Private Placement, which occurred on August 6, 2026. However, the issuer may accelerate the expiration of the Warrants, subject to specified conditions. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are included within 303,030 Investor Units (the "Units") purchased by the reporting person from the issuer for a price of $0.33 per Unit in a private placement transaction (the "Private Placement"). Each Unit is comprised of one (1) share of the issuer's common stock (a "Share") plus one half (1/2) of a Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to purchase one (1) Share (a "Warrant Share") at an exercise price of $0.45 per Warrant Share.
F2: The Warrants may be exercised for 36 months following the completion of the Private Placement, which occurred on August 6, 2026. However, the issuer may accelerate the expiration of the Warrants, subject to specified conditions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 28, 2026 Filed Sep 30, 2026 06:11 UTC | Caring Brands, Inc. CABR · Entity 7825 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001493152-26-044990 · ownership.xml · derivative · entry 1 Meadows Brian · CIK 0002055703 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-09-28 F1 · date: On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan. F2 · derivative.exercise_date: The options vested immediately on September 28, 2026. Read SEC document |
| August 06, 2026 Filed Aug 7, 2026 18:15 UTC | JONES SODA CO. JSDA · Entity 7351 | PurchaseCommon Stock Warrant (right to buy) · Derivative | 151,515 | Not disclosed Strike: $0.45 | Not disclosed |
DisclosureSEC source: 0001493152-26-036525 · ownership.xml · derivative · entry 2 Meadows Brian · CIK 0002055703 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,515 Underlying: Common Stock · 151,515 shares Expires 2029-08-06 F1 · security: The reported securities are included within 303,030 Investor Units (the "Units") purchased by the reporting person from the issuer for a price of $0.33 per Unit in a private placement transaction (the "Private Placement"). Each Unit is comprised of one (1) share of the issuer's common stock (a "Share") plus one half (1/2) of a Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to purchase one (1) Share (a "Warrant Share") at an exercise price of $0.45 per Warrant Share. F1 · shares: The reported securities are included within 303,030 Investor Units (the "Units") purchased by the reporting person from the issuer for a price of $0.33 per Unit in a private placement transaction (the "Private Placement"). Each Unit is comprised of one (1) share of the issuer's common stock (a "Share") plus one half (1/2) of a Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to purchase one (1) Share (a "Warrant Share") at an exercise price of $0.45 per Warrant Share. F1 · price: The reported securities are included within 303,030 Investor Units (the "Units") purchased by the reporting person from the issuer for a price of $0.33 per Unit in a private placement transaction (the "Private Placement"). Each Unit is comprised of one (1) share of the issuer's common stock (a "Share") plus one half (1/2) of a Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to purchase one (1) Share (a "Warrant Share") at an exercise price of $0.45 per Warrant Share. F2 · derivative.expiration_date: The Warrants may be exercised for 36 months following the completion of the Private Placement, which occurred on August 6, 2026. However, the issuer may accelerate the expiration of the Warrants, subject to specified conditions. Read SEC document |
| August 06, 2026 Filed Aug 7, 2026 18:15 UTC | JONES SODA CO. JSDA · Entity 7351 | PurchaseCommon Stock | 303,030 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-26-036525 · ownership.xml · nonDerivative · entry 1 Meadows Brian · CIK 0002055703 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,030 F1 · shares: The reported securities are included within 303,030 Investor Units (the "Units") purchased by the reporting person from the issuer for a price of $0.33 per Unit in a private placement transaction (the "Private Placement"). Each Unit is comprised of one (1) share of the issuer's common stock (a "Share") plus one half (1/2) of a Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to purchase one (1) Share (a "Warrant Share") at an exercise price of $0.45 per Warrant Share. F1 · price: The reported securities are included within 303,030 Investor Units (the "Units") purchased by the reporting person from the issuer for a price of $0.33 per Unit in a private placement transaction (the "Private Placement"). Each Unit is comprised of one (1) share of the issuer's common stock (a "Share") plus one half (1/2) of a Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to purchase one (1) Share (a "Warrant Share") at an exercise price of $0.45 per Warrant Share. Read SEC document |
| March 27, 2026 Filed May 21, 2026 18:47 UTC | JONES SODA CO. JSDA · Entity 7351 | GrantEmployee stock · Derivative | 750,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001493152-26-024789 · ownership.xml · derivative · entry 1 Meadows Brian · CIK 0002055703 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 750,000 shares Expires 2036-03-26 F1 · derivative.exercise_date: The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 250,000 Stock Options shall vest on March 27, 2027, (ii) 250,000 Stock Options shall vest on March 27, 2028, and (iii) the remaining 250,000 Stock Options shall vest on March 27, 2029, each subject to Mr. Meadows' continued service with the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.